Nicaragua vs Tunisia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Nicaragua
96.0%
in 2025
Tunisia
96.0%
in 2025
Nicaragua rank
27th
Tunisia rank
27th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Nicaragua
- Tunisia
How they compare
Nicaragua currently reports 96.0% against 96.0% in Tunisia, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Tunisia ahead.
Nicaragua ranks 27th and Tunisia ranks 27th of 194 countries.
Nicaragua has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Nicaragua | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 85.3% | 0.0% | 85.3% | Nicaragua |
| 2020s | 97.8% | 95.2% | 2.7% | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Nicaragua or Tunisia?
- Nicaragua, at 96.0% against 96.0% in Tunisia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Nicaragua and Tunisia?
- 0.0%, with Nicaragua ahead.
- How many years of comparable data are there for Nicaragua and Tunisia?
- 18 years are reported by both, from 2008 to 2025.
- How do Nicaragua and Tunisia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Nicaragua ranks 27th and Tunisia ranks 27th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.